PHVS – pharvaris n.v. - ordinary shares (US:NASDAQ)
Stock Stats
News
Pharvaris (NASDAQ: PHVS) had its price target raised by analysts at JMP Securities from $46.00 to $55.00. They now have a "market outperform" rating on the stock.
Pharvaris Outlines 2025 Strategic Priorities
Pharmaceutical Executive® announces winners of 2024 Pharmaceutical Executive APEX Awards [Yahoo! Finance]
Form 6-K Pharvaris N.V. For: Jan 13
Form 144 Pharvaris N.V. Filed by: Conn Morgan
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.